Curevac N V Receivables Turnover Ratio (CVAC), from the second quarter 2025 to the second quarter 2024 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Curevac N v   (NASDAQ: CVAC)
 

Curevac N V Accounts Receivables Turnover Ratio from the second quarter 2025 to the second quarter 2024

Quarterly Results, Trends, Rankings, Statistics


Curevac N V 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2025 to a ratio of 139.4, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2025. Average receivable collection period, for the Curevac N V in Jun 30 2025 quarter, has decreased to 3 days, compared to 4 days, in the Mar 31 2025 quarter.

If we take a look into Healthcare sector 222 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2025 from 474 to 1869.

What is Receivable Turnover Ratio?
What is Curevac N V Selling?


What is Receivable Turnover Ratio?





CVAC Receivables Turnover Ratio (Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
0
III. Quarter
0
II. Quarter
Y / Y Receivable Change -96.95 % -87.2 % -8.05 % -1.74 % -1.74 %
Y / Y Revenue Change -90.92 % -93 % 895.54 % 2924.68 % 88.34 %
Receivable Turnover Ratio (TTM) 139.4 96.3 75.71 40.02 6.76
CVAC's Total Ranking # 1869 # 474 # # #
Accounts Receivable average collection period days 3 4 5 9 54
Seq. Receivable Change -76.16 % -86.14 % -7.58 % 0 % 0 %
Seq. Revenue Change 50.11 % -99.84 % 10.46 % 3391.52 % 15.72 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 54
Healthcare Sector # 223
Overall Market # 1869

Receivable Turnover Ratio Statistics
High Average Low
0.67 0.27 0.07
(Dec 31 2024)   (Dec 31 2023)






Financial Statements
Curevac N V 's Accounts Receivable $ 0 Millions Visit CVAC's Balance sheet
Curevac N V 's Sales TTM $ 1,144 Millions Visit CVAC's Income Statement
Sources of CVAC's Revenues Visit CVAC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CVAC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CVAC's Growth Rates CVAC's Roa CVAC's Inventory Turnover Ratio CVAC's Dividend Comparisons
CVAC's Profitability Ratios CVAC's Roi CVAC's Asset Turnover Ratio CVAC's Dividend Growth
CVAC's Valuation Ratios CVAC's Roe CVAC's Financial Strength Ratios CVAC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2025 Receivable at quarter ending Jun 30 2025
Warby Parker Inc   580.53 $ 820.582  Millions$ 1.414  Millions
Bicycle Therapeutics Plc  567.09 $ 19.281  Millions$ 0.034  Millions

Date modified: 2026-10-15T05:23:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.